Advancing Rare Disease Research through Precision Biotechnological Solutions
Lentiviruses, stable cell lines, and customized organoids for biomedical research
Spin-off from GIRBER-USAL: Science with Real Impact
At RareBioTech we translate academic findings into practical tools for researchers, clinicians, and pharmaceutical companies. Our technology accelerates the development of biomedical research and preclinical models for rare diseases.
What Do We Offer?
Lentivirus Production
High-efficiency vectors for biomedical research and CRISPR.
Stable Cell Lines
Genetically edited models for your in vitro assays.
Customised Organoids
Recreates rare diseases in three-dimensional models for use in preclinical research.
For Whom?
For Researchers
Lentiviral vectors, genetically edited cell lines, customised 3D organoids.
For Doctors and Hospitals
Advanced genetic diagnosis through functional cell biology.
For Pharmaceutical Companies
Biomarkers, assays, cost reduction
and GMP scale-up.
Do you require any additional services?
RareBioTech Innovation in Biomedical Research and Cellular Models from Salamanca
Our laboratory at the Abioinnova bioincubator (Salamanca) develops biotechnological products, therapeutic lentiviruses, stable cell lines, and organoids to accelerate research and support biomedical investigation.
